Healthcare Touched New Highs: Select Medical Holdings (NYSE:SEM), Corcept Therapeutics Incorporated (NASDAQ:CORT), Novartis (NYSE:NVS), Becton, Dickinson (NYSE:BDX)

Select Medical Holdings Corporation (NYSE:SEM), announced that the company has completed its private placement of $110.0 million in aggregate principal amount of its 6.375% senior notes due 2021 (the “Additional Notes”) as additional notes under the indenture pursuant to which it previously issued $600.0 million of 6.375% senior notes due 2021. Select intends to use the net proceeds of the offering of the Additional Notes, … Continue reading Healthcare Touched New Highs: Select Medical Holdings (NYSE:SEM), Corcept Therapeutics Incorporated (NASDAQ:CORT), Novartis (NYSE:NVS), Becton, Dickinson (NYSE:BDX)

John Bellich04/0104/01

FB Nasdaq FB Facebook

Biotech Bullish Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Idera Pharmaceuticals (NASDAQ:IDRA), CytRx Corporation (NASDAQ:CYTR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is 6.6% higher, as traders digest rumors that Jazz Pharmaceuticals plc (NASDAQ:JAZZ) was willing to pay over $20 per share to buy the firm. Digging deeper, speculators are expecting ARIA to remain south of $9 in the short term, buying to open the April 9 and May 9 puts. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was 5.00% in last session and … Continue reading Biotech Bullish Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Idera Pharmaceuticals (NASDAQ:IDRA), CytRx Corporation (NASDAQ:CYTR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Jason Knox03/3103/31

Healthcare New Highs: China Cord Blood Corporation (NYSE:CO), Corcept Therapeutics (NASDAQ:CORT), Nordion (NYSE:NDZ), Vision-Sciences (NASDAQ:VSCI)

Stocks Almost Family and Chemed hold a Zacks Rank #1(Strong Buy) and China Cord Blood Corporation (NYSE:CO) holds a Zacks Rank #2 (Buy). With favorable Zacks Ranks, these stocks may be better selections at this time. China Cord Blood Corporation (NYSE:CO) stock performance was 3.26% in last session and finished the day at $4.44. Traded volume was 777.52K shares in the last session and the … Continue reading Healthcare New Highs: China Cord Blood Corporation (NYSE:CO), Corcept Therapeutics (NASDAQ:CORT), Nordion (NYSE:NDZ), Vision-Sciences (NASDAQ:VSCI)

Mark Doerr03/1003/10

Investors Watch List: Salesforce.com (NYSE:CRM), Corcept Therapeutics Incorporated (NASDAQ:CORT), Rally Software Development Corp. (NYSE:RALY), Vodafone (NASDAQ:VOD), First Commonwealth Financial (NYSE:FCF)

On 21 AUG Salesforce.com, Inc (NYSE:CRM) last announced its earnings results on Thursday. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.01. The company had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the company posted $0.09 earnings per share. … Continue reading Investors Watch List: Salesforce.com (NYSE:CRM), Corcept Therapeutics Incorporated (NASDAQ:CORT), Rally Software Development Corp. (NYSE:RALY), Vodafone (NASDAQ:VOD), First Commonwealth Financial (NYSE:FCF)

John Meady08/2608/26

Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

La Jolla Pharmaceutical Company (NASDAQ:LJPC) (the “Company” or “La Jolla”) a leader in the development of therapeutics targeting significant unmet life-threatening diseases today announced that George Tidmarsh M.D. Ph.D. President and Chief Executive Officer will provide a corporate overview at the 2014 Wedbush Securities Life Sciences Conference taking place August 12-13 in New York City. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) belongs to Healthcare sector. Its … Continue reading Worth Watching Stocks : La Jolla Pharmaceutical (NASDAQ:LJPC), Corcept (NASDAQ:CORT), Grupo Aeroportuario (NASDAQ:OMAB), Facebook (NASDAQ:FB), Elephant Talk Communications (NYSEMKT:ETAK)

Jayne Crisman08/1208/12

Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Aegis started coverage on shares of Recro Pharma Inc. (NASDAQ:REPH) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $40.00 price target on the stock. Aegis’ price objective suggests a potential upside of 412.16% from the company’s current price. Recro Pharma Inc (NASDAQ:REPH) stock performance was -7.30% in last session and finished the day at $7.24. Traded … Continue reading Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Mark Doerr06/1706/17